Correction: A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Zhang Z, Mao H, Du X, Zhu J, Xu Y, Wang S, Xu X, Ji P, Yu Y, Cao B, Han K, Hou T, Xu Z, Kong Y, Jiang G, Tang X, Qiao C, Mao X.
Zhang Z, et al. Among authors: hou t.
Oncotarget. 2016 Dec 6;7(49):81972. doi: 10.18632/oncotarget.13803.
Oncotarget. 2016.
PMID: 28082727
Free PMC article.
No abstract available.